Handing Off Survivors From Oncology to Primary Care
The handoff is where surveillance is most often lost. What a transfer needs to contain, who owns what afterwards, and how to confirm the receiving clinician actually accepted the plan.
The transfer from oncology follow-up to primary care is where survivorship surveillance is most often lost. Not because anyone disagrees about what should happen, but because nobody is named, the exposure history does not travel, and no one confirms the receiving clinician accepted the plan.
What must travel with the patient
Diagnosis, stage and dates; chemotherapy agents with cumulative anthracycline dose; HER2-targeted, VEGF-pathway, kinase-inhibitor and checkpoint-inhibitor exposure; radiation fields and total dose; surgical history; transplant or cellular therapy; endocrine or androgen-deprivation therapy; and significant treatment toxicities.
Then the forward-looking half: recurrence surveillance plan, cardiovascular surveillance plan including imaging modality and interval, second-cancer screening, bone, endocrine and fertility considerations, vaccination status, and current medications.
Name an owner for every line
For each item, record who holds it and for how long: oncology, primary care, cardiology or cardio-oncology, or a shared arrangement with a defined review point. Undefined ownership is the single most reliable predictor that an item quietly stops happening.
State the re-referral trigger explicitly — which symptoms, which imaging findings, which biomarker changes send the patient back, and to whom, without a new workup starting from zero.
Cite the guideline and date it
Surveillance intervals differ between societies and are revised. Recording which guidance and which version informed the plan lets a future clinician tell whether the plan is current or simply old, and makes revisiting it a decision rather than an argument.
This is the practical value of a guideline comparison view: it shows where recommendations agree and where the choice was genuinely discretionary.
Confirm the handoff happened
Treat transfer as a two-sided event. A brief acknowledgement from the receiving clinician, a scheduled first survivorship visit, and a patient-held copy of the same plan convert a sent document into an accepted responsibility.
Flag the higher-risk groups for closer confirmation: childhood, adolescent and young-adult survivors, high cumulative anthracycline dose, chest or mediastinal radiation, transplant recipients, and anyone already showing reduced cardiac function.
Design for the transitions after this one
Patients change insurers, move, and change practices. A plan that exists only inside one EHR will not survive those events, so the patient-held version is infrastructure, not courtesy.
Structured, portable formats — including standards-based exports where available — make the next handoff cheaper than this one. That is the intent behind Life Spark's transition plan and shared care tooling.
Frequently asked questions
- What should a survivorship care handoff include?
- Structured treatment exposures, a surveillance schedule with named owners and intervals, explicit re-referral triggers, current medications, and a patient-held copy of the same plan.
- Why is surveillance lost after transfer to primary care?
- Most often because ownership was never assigned, the exposure history did not travel in a structured form, and no one confirmed the receiving clinician accepted the plan.